Advances in Molecular OncologyAdvances in Molecular OncologyУспехи молекулярной онкологии2313-805X2413-3787Publishing House ABV Press20810.17650/2313-805X-2019-6-1-63-72RESEARCH ARTICLESЭКСПЕРИМЕНТАЛЬНЫЕ СТАТЬИStudy of interaction between extracellular matrix proteins and receptors of CD133+ stem cells and CD133– differentiated glioma cellsИзучение взаимодействия белков внеклеточного матрикса с рецепторами CD133+ стволовых клеток и CD133– дифференцированных клеток глиомыhttps://orcid.org/0000-0002-0401-9900ShevchenkoV. E.ШевченкоВ. Е.
Russian Federation

24 Kashirskoe Shosse, Moscow 115478.

Шевченко Валерий Евгеньевич.

115478 Москва, Каширское шоссе, 24.

vshev2015@yandex.ruhttps://orcid.org/0000-0003-3654-3069BryukhovetskiyI. S.БрюховецкийИ. С.
Russian Federation

8 Sukhanova St., Vladivostok 690091; 17 Pal’chevskogo St., Vladivostok690059.

690091 Владивосток, ул. Суханова, 8; 690059 Владивосток, ул. Пальчевского, 17.

 

https://orcid.org/0000-0003-1433-5533SavchenkoE. A.СавченкоЕ. А.
Russian Federation

13A Kolomenskiy Proezd, Moscow 115446.

115446 Москва, Коломенский проезд, 13А.

https://orcid.org/0000-0002-0154-8604ArnotskayaN. E.АрноцкаяН. Е.
Russian Federation

24 Kashirskoe Shosse, Moscow 115478.

115478 Москва, Каширское шоссе, 24.

Research Institute of Carcinogenesis, N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of RussiaНИИ канцерогенеза Национального медицинского исследовательского центра онкологии им. Н.Н. Блохина Минздрава РоссииSchool of Biomedicine, Far Eastern Federal UniversityШкола биомедицины Дальневосточного федерального университетаNational Scientific Center of Marine Biology, Far Eastern Branch of the Russian Academy of SciencesНациональный научный центр морской биологии Дальневосточного отделения РАНLimited Liability Company “APTO-FARM”ООО «АПТО-ФАРМ»150120196163722804201928042019Copyright ©; 2019, Shevchenko V.E., Bryukhovetskiy I.S., Savchenko E.A., Arnotskaya N.E.Copyright ©; 2019, Шевченко В.Е., Брюховецкий И.С., Савченко Е.А., Арноцкая Н.Е.2019Shevchenko V.E., Bryukhovetskiy I.S., Savchenko E.A., Arnotskaya N.E.Шевченко В.Е., Брюховецкий И.С., Савченко Е.А., Арноцкая Н.Е.https://creativecommons.org/licenses/by/4.0https://umo.abvpress.ru/jour/article/view/208

extracellular matrixglioma stem cellsglioblastoma multiformeproteomemass-spectrometryвнеклеточный матриксстволовые клетки глиомымультиформная глиобластомапротеоммасс-спектрометрияHolland E.C. Glioblastoma multiforme: the terminator. Proc Natl Acad Sci USA 2000;97(12):6242-4. PMID: 10841526.Huse J.T., Holland E.C. Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma. Nat Rev Cancer 2010;10(5):319—31. DOI: 10.1038/nrc2818. PMID: 20414201.Beauchesne P. Extra-neural metastases of malignant gliomas: Myth or reality? Cancers 2011;3:461-77. DOI: 10.3390/cancers3010461. PMID: 24212625.Bolteus A.J., Berens M.E., Pilkington G.J. Migration and invasion in brain neoplasms. Curr Neurol Neurosci Rep 2001;1(3):225—32. PMID: 11898522.Cuddapah V.A., Robel S., Watkins S. et al. A neurocentric perspective on glioma invasion. Nat Rev Neurosci 2014;15(7):455—65. DOI: 10.1038/nrn3765. PMID: 24946761.Claes A., Idema A.J., Wesseling P. Diffuse glioma growth: a guerilla war. Acta Neuropathol 2007;114(5):443—58. DOI: 10.1007/s00401-007-0293-7. PMID: 17805551.Cayre M., Canoll P., Goldman J.E. Cell migration in the normal and pathological postnatal mammalian brain. Prog Neurobiol 2009;88(1):41—63. DOI: 10.1016/j.pneurobio.2009.02.001. PMID: 19428961.Le Clainche C., Carlier M.F. Regulation of actin assembly associated with protrusion and adhesion in cell migration. Physiol Rev 2008;88(2):489—513. DOI: 10.1152/physrev.00021.2007. PMID: 18391171.Huttenlocher A., Horwitz A.R. Integrins in cell migration. Cold Spring Harbor Perspect Biol 2011;3(9):a005074. DOI: 10.1101/cshperspect.a005074. PMID: 21885598.Roos A., Ding Z., Loftus J.C., Tran N.L. Molecular and microenvironmental determinants of glioma stem-like cellsurvival and invasion. Front Oncol 2017;7:120. DOI: 10.3389/fonc.2017.00120. PMID: 28670569.Kang S.K., Park J.B., Cha S.H. Multipotent, dedifferentiated cancer stemlike cells from brain gliomas. Stem Cells Dev 2006;15(3):423—35. DOI: 10.1089/scd.2006.15.423. PMID: 16846378.Chen J., McKay R.M., Parada L.F. Malignant glioma: lessons from genomics, mouse models and stem cells. Cell 2012;149(1):36—47. DOI: 10.1016/j.cell.2012.03.009. PMID: 22464322.Persano L., Rampazzo E., Basso G. et al. Glioblastoma cancer stem cells: Role of the microenvironment and therapeutic targeting. Biochem Pharmacol 2013;85(5):612—22. DOI: 10.1016/j.bcp.2012.10.001. PMID: 23063412.Ortensi B., Osti D., Pellegatta S. et al. Rai is a new regulator of neural progenitor migration and glioblastoma invasion. Stem Cells 2012;30(5):817—32. DOI: 10.1002/stem.1056. PMID: 22311806.Cheng L., Wu Q., Guryanova O.A. et al. Elevated invasive potential of glioblastoma stem cells. Biochem Biophys Res Commun 2011;406(4):643—8. DOI: 10.1016/j.bbrc.2011.02.123. PMID: 21371437.Safa A.R., Saadatzadeh M.R., Cohen-Gadol A.A. et al. Glioblastoma stem cells (GSCs) epigenetic plasticity and interconversion between differentiated non-GSCs and GSCs. Genes Dis 2015;2(2):152—63. DOI: 10.1016/j.gendis.2015.02.001. PMID: 26137500.Tirino V., Desiderio V., Paino F. et al. Methods for cancer stem cell detection and isolation. Methods Mol Biol 2012;879:513—29. DOI: 10.1007/978-1-61779-815-3_32. PMID: 22610581.Bryukhovetskiy A., Shevchenko V., Kovalev S. et al. To the novel paradigmof proteome-based cell therapy of tumors: through comparative proteome mapping of tumor stem cells and tissue-specific stem cells of humans. Cell Transplantation 2014;9:1—42. DOI: 10.3727/096368914X684907. PMID: 25303679.Singh S.K., Hawkins C., Clarke I.D. et al. Identification of human brain tumour initiating cells. Nature 2004;432(7015):396—401. DOI: 10.1038/nature03128. PMID: 15549107.Beier D., Hau P., Proescholdt M. et al. CD133(+) and CD133(—) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res 2007;67(9):4010—5. PMID: 17483311.Beier C.P., Beier D. CD133 negative cancer stem cells in glioblastoma. Front Biosci (Elite Ed) 2011;3:701—10. PMID: 21196345.Munthe S., Petterson S.A., Dahlrot R.H. et al. Glioma cells in the tumor periphery have a stem cell phenotype. PloS One 2016;11(5):e0155106. DOI: 10.1371/journal.pone.0155106. PMID: 27171431.Cheng L., Huang Z., Zhou W. et al. Glioblastoma stem cells generate vascular pericytes to support vessel function and tumor growth. Cell 2013;153(1):139—52. DOI: 10.1016/j.cell.2013.02.021. PMID: 23540695.Hambardzumyan D., Bergers G. Glioblastoma: defining tumor niches. Trends Cancer 2015;1(4):252—65. DOI: 10.1016/j.trecan.2015.10.009. PMID: 27088132.Matsukado Y., Maccarty C.S., Kernohan J.W. The growth of glioblastoma multiforme (astrocytomas, grades 3 and 4) in neurosurgical practice. J Neurosurg 1961;18:636—44. DOI: 10.3171/jns.1961.18.5.0636. PMID: 13768222.Muller C., Holtschmidt J., Auer M. et al. Hematogenous dissemination of glioblastoma multiforme. Sci Transl Med 2014;6(247):247ra101. DOI: 10.1126/scitransLmed.3009095. PMID: 25080476.Glass R., Synowitz M. CNS macrophages and peripheral myeloid cells in brain tumours. Acta Neuropathol 2014;128:347-62. DOI: 10.1007/s00401-014-1274-2. PMID: 24722970.Wu C. Focal adhesion: a focal point in current cell biology and molecular medicine. Cell Adhesion Mig 2007;1(1):13—8. PMID: 19262093.Arnaout M.A., Goodman S.L., Xiong J.P. Structure and mechanics of integrin-based cell adhesion. Curr Opin Cell Biol 2007;19(5):495—507. DOI: 10.1016/j.ceb.2007.08.002. PMID: 17928215.Humphries J.D., Byron A., Humphries M.J. Integrin ligands at a glance. J Cell Sci 2006; 119(Pt 19):3901—3. DOI: 10.1242/jcs.03098. PMID: 16988024.Madamanchi A., Santoro SA., Zutter M.M. alpha2beta1 Integrin. Adv Exp Med Biol 2014;819:41-60. DOI: 10.1007/978-94-017-9153-3_3. PMID: 25023166.Danen E.H. Integrins: regulators of tissue function and cancer progression. Curr Pharm Des 2005;11(7):881—91. PMID: 15777241.Xie J.J., Guo J.C., Wu Z.Y. et al. Integrin alpha5 promotes tumor progression and is an independent unfavorable prognostic factor in esophageal squamous cell carcinoma. Hum Pathol 2016;48:69-75. DOI: 10.1016/j.humpath.2015.09.029. PMID: 26772401.Feng L., Ma J., Ji H. et al. miR-330-5p suppresses glioblastoma cell proliferation and invasiveness through targeting ITGA5. Biosci Rep 2017;37(3). DOI: 10.1042/BSR20170019. PMID: 28336765.Skuli N., Monferran S., Delmas C. et al. Alphavbeta3/alphavbeta5 integrins-FAK-RhoB: a novel pathway for hypoxia regulation in glioblastoma. Cancer Res 2009;69(8):3308—16. DOI: 10.1158/0008-5472.CAN-08-2158. PMID: 19351861.Desgrosellier J.S., Cheresh D.A. Integrins in cancer: biological implications and therapeutic opportunities. Nat Rev Cancer 2010;10(1):9—22. DOI: 10.1038/nrc2748. PMID: 20029421.Klekner A., Hutoczki G., Virga J. et al. Expression pattern of invasionrelated molecules in the peritumoral brain. Clin Neurol Neurosurg 2015;139:138—43. PMID: 26451999.Serres E., Debarbieux F., Stanchi F. et al. Fibronectin expression in glioblastomas promotes cell cohesion, collective invasion of basement membrane in vitro and orthotopic tumor growth in mice. Oncogene 2014;33(26):3451—62. DOI: 10.1038/onc.2013.305. PMID: 23912459.Ryan M.C., Christiano A.M., Engvall E. et al. The functions of laminins: lessons from in vivo studies. Matrix Biol 1996;15(6):369—81. PMID: 9049976.Caffo M., Germano A., Caruso G. et al. An immunohistochemical study of extracellular matrixproteins laminin, fibronectin and type IV collagen in paediatric glioblastoma multiforme. Acta Neurochir (Wien) 2004;146(10):1113—8. DOI: 10.1007/s00701-004-0344-y. PMID: 15309586.Yu Q., Xue Y., Liu J. et al. Fibronectin promotes the malignancy of glioma stemlike cells via modulation of cell adhesion, differentiation, proliferation and chemoresistance. Front Mol Neurosci 2018;11:130. DOI: 10.3389/fnmol.2018.00130. PMID: 29706869.Yeh W.L., Lu D.Y., Liou H.C. et al. A forward loop between glioma and microglia: glioma-derived extracellular matrix-activated microglia secrete IL-18 to enhance the migration of glioma cells. J Cell Physiol 2012;227(2):558—68. DOI: 10.1002/jcp.22746. PMID: 21442623Wiranowska M., Ladd S., Moscinski L.C. et al. Modulation of hyaluronan production by CD44 positive glioma cells. Int J Cancer 2010;127(3):532—42. DOI: 10.1002/ijc.25085. PMID: 19957333.Turley E.A., Noble P.W., Bourguignon L.Y. Signaling properties of hyaluronan receptors. J Biol Chem 2002;277(7):4589—92. DOI: 10.1074/jbc.R100038200. PMID: 11717317.Anido J., Saez-Borderias A., Gonzalez-Junca A. et al. TGF-beta receptor inhibitors target the CD44(high)/Id1(high) glioma-initiating cell population in human glioblastoma. Cancer Cell 2010;18(6):655—68. DOI: 10.1016/j.ccr.2010.10.023. PMID: 21156287.Hamilton S.R., Fard S.F., Paiwand F.F. et al. The hyaluronan receptors CD44 and Rhamm(CD168) form complexes with ERK1,2 that sustain high basal motility in breast cancer cells. J Biol Chem 2007;282(22):16667—80. DOI: 10.1074/jbc.M702078200. PMID: 17392272.Zhao T., Guan L., Yu Y. et al. Kindlin-2 promotes genome instability in breast cancer cells. Cancer Lett 2013;330(2):208—16. DOI: 10.1016/j.canlet.2012.11.043. PMID: 23211537.Ghobrial I.M., Witzig T.E., Adjei A.A. Targeting apoptosis pathways in cancer therapy. CA Cancer J Clin 2005;55(3):178—94. PMID: 15890640.Kim Y.M., Kim E.C., Kim Y. The human lysyl oxidase-like 2 protein functions as an amine oxidase toward collagen and elastin. Mol Biol Rep 2011;38(1):145—9. DOI: 10.1007/s11033-010-0088-0. PMID: 20306300.Du X.G., Zhu M.J. Clinical relevance of lysyl oxidase-like 2 and functional mechanisms in glioma. Onco Targets Ther 2018;11:2699—708. DOI: 10.2147/OTT.S164056. PMID: 29785119.Guo Q., Song Y., Zhang H. et al. Detection of hypermethylated fibrillin-1 in the stool samples of colorectal cancer patients. Med Oncol 2013;30(4):695. DOI: 10.1007/s12032-013-0695-4. PMID: 23963856.Cierna Z., Mego M., Jurisica I. et al. Fibrillin-1 (FBN-1) a new marker of germ cell neoplasia in situ. BMC Cancer 2016;16:597. DOI: 10.1186/s12885-016-2644-z. PMID: 27487789.